Abstract
The solution structure of the 1,4-bis(2'-deoxyadenosin-N6-yl)-2R,3R-butanediol crosslink arising from N6-dA alkylation of nearest neighbor adenines by butadiene diepoxide (BDO2) was determined in the oligodeoxynucleotide 5' - d(CGGACXYGAAG)•d(CTTCTCGTCCG)-3'. This oligodeoxynucleotide contained codon 61 (underlined) of the human N-ras protooncogene. The cross link was accommodated in the major groove of duplex DNA. At the 5'-side of the crosslink there was a break in Watson-Crick base pairing at base pair X6•T17, whereas at the 3'-side of the crosslink at base pair Y7•T16, base pairing was intact. Molecular dynamics calculations carried out using a simulated annealing protocol, and restrained by a combination of 338 interproton distance restraints obtained from 1H NOESY data and 151 torsion angle restraints obtained from 1H and 31P COSY data, yielded ensembles of structures with good convergence. Helicoidal analysis indicated an increase in base pair opening at base pair X6•T17, accompanied by a shift in the phosphodiester backbone torsion angle β P5'-O5'-C5'-C4' at nucleotide X6. The rMD calculations predicted that the DNA helix was not significantly bent by the presence of the four-carbon crosslink. This was corroborated by gel mobility assays of multimers containing non-hydroxylated four carbon N6,N6-dA crosslinks, which did not predict DNA bending. The rMD calculations suggested the presence of hydrogen bonding between the hydroxyl group located on the β-carbon of the fourcarbon crosslink, and T17 O4, which perhaps stabilized the base pair opening at X6•T17 and protected the T17 imino proton from solvent exchange. The opening of base pair X6•T17 altered base stacking patterns at the crosslink site and induced slight unwinding of the DNA duplex. The structural data are interpreted in terms of biochemical data suggesting that this crosslink is bypassed by a variety of DNA polymerases, yet is significantly mutagenic [Kanuri, M., Nechev, L. V., Tamura, P. J., Harris, C. M., Harris, T. M., and Lloyd, R. S. (2002) Chem. Res. Toxicol. 15, 1572–1580].
1,3-Butadiene (CAS RN 106-99-0) (BD)1 is used in the manufacture of styrene-butadiene rubber (SBR) (1, 2); several billion lbs/yr are produced in the United States. It is a combustion product from automobile emissions (3) and cigarette smoke (4). BD is genotoxic and is a carcinogen in rodents, particularly in mice (5–7) and also in rats (8). BD was classified by the United States Environmental Protection Agency as "carcinogenic to humans by inhalation" (9). The International Agency for Cancer Research (IARC) lists BD as a "probable human carcinogen" (Group 2A) (10–12). Chronic human exposure in the SBR industry may induce genotoxic effects (13–15) and is correlated with increased risk for leukemia (1, 16–24).
BD is epoxidized primarily by cytochrome P450 2E1, but also by cytochrome P450 2A6, to form 1,2-epoxy-3-butenes (BDO) (Scheme 1) (25, 26). These may be further oxidized by cytochrome P450 2E1 or 3A4 to form 1,2:3,4-diepoxybutanes (BDO2) (25, 27–31). Hydrolysis of BDO mediated by epoxide hydrolase forms 1,2-dihydroxy-3-butenes (29, 32, 33), which are metabolized by cytochrome P450 to hydroxymethylvinylketone (HMVK) (34). Either BDO2 or the 1,2-dihydroxy-3-butenes undergo cytochrome P450-mediated oxidation to form 1,2-dihydroxy-3,4-epoxybutanes (BDE) (29, 32, 35). Thus, proximate electrophiles arising from BD metabolism include BDO, BDO2, and BDE, and potentially, HMVK (36).
Scheme 1.
Reactive Metabolites of Butadiene.
The diepoxide BDO2 is highly genotoxic (2, 10, 37), probably due to its potential to form DNA-DNA (38–41) and DNA-protein crosslinks, the latter of which have been observed in mice (42, 43). Mice have been shown to possess greater sensitivity to butadiene exposure than rats, and this is attributed to their efficient oxidation of BD to BDO2 (44, 45), presumably facilitating DNA crosslinking. Butadiene genotoxicty was further enhanced in knockout mice lacking a functional microsomal epoxide hydrolase gene (46). Polymorphisms in the human epoxide hydrolase gene may also contribute to differences in BD genotoxicty within the human population (47, 48).
The predominant DNA crosslink induced by BDO2 involves interstrand bis-alkylation at N7-dG in 5'-GNC-3' sequences (40). This crosslink was isolated from DNA and characterized by mass spectrometry (41). Recently, additional guanine-adenine DNA interstrand crosslinks induced by BDO2, including an N7-dG-N6-dA crosslink, were characterized by mass spectrometry (49). The recovery of an interstrand crosslink involving N6-dA was perhaps unexpected since, with respect to alkylation by butadiene epoxide, the N6-dA exocyclic amine is less reactive than the N1 imine. The prevailing hypothesis posits that N6 alkylation products of butadiene epoxides result from initial alkylation at the N1 position, followed by Dimroth rearrangement (50, 51). The BDT N1-dA adduct has been identified in humans exposed occupationally to BD (52). The N6-dA BDT adduct was identified in Chinese Hamster ovary cells (53).
The bis-alkylation of tandem deoxyadenosines to yield intrastrand N6,N6-dA R,R crosslinks is anticipated to be a rare occurrence. This adduct has not yet been reported from mass spectrometry analysis of DNA exposed to BDO2 (49, 54). However, its synthetic accessibility (55) facilitated biochemical structure-activity studies. As compared to N6-dA monoadducts arising from BDO or BDE (56, 57), the N6,N6-dA R,R crosslink was significantly more mutagenic. It was examined as to site-specfic mutagenesis, both in Escherichia coli and in COS-7 cells (55). In both systems, the primary mutations were A→G transitions observed at the 3’ adenine of the crosslink. The levels of mutations observed in the COS-7 cells were significantly greater than were observed in the bacterial system.
Both the R,R and S,S stereoisomers of this N6,N6-dA intrastrand crosslink were bypassed by a variety of DNA polymerases in vitro (55), suggesting that they did not pose severe blocks to replication; mutagenesis in E. coli may be due to DNA polymerase II-mediated lesion bypass (58). It was proposed that these BDO2-induced crosslinks were accommodated within the major groove, similar to several N6-dA adducts of styrene oxide, which also did not pose severe blocks to replication (59, 60). This was in contrast to the corresponding N2,N2-dG (R,R) and (S, S) intrastrand crosslinks, which were severe replication blocks when examined in vitro (61).
The present work characterizes structural perturbation to the ras61 oligodeoxynucleotide caused by the 1,4-bis(2'-deoxyadenosin-N6-yl)-2R,3R-butanediol crosslink. Molecular dynamics calculations restrained by interproton distances and torsion angle restraints obtained from NMR spectroscopy indicate that the crosslinked moiety is accommodated in the major groove of the DNA double helix. Watson-Crick base pairing is disrupted at position X6•T17, the 5'-side of the intrastrand crosslink. Helicoidal analysis suggests an opening of this base pair. Potential hydrogen bond formation between the β-hydroxyl group of the crosslink, and T17 O4, the nucleotide complementary to X6, shields the T17 imino hydrogen from exchange with solvent. In contrast, Watson-Crick base pairing is intact at position Y7•T16, the 3'-side of the crosslink.
MATERIALS AND METHODS
Sample Preparation
The oligodeoxynucleotides 5'-d(CGGACAAGAAG)-3' and 5'- d(CTTCTTGTCCG)-3' were synthesized by the Midland Certified Reagent Co. (Midland, TX) and purified by anion-exchange chromatography. The crosslinked oligodeoxynucleotide 5'-d(CGGACXYGAAG)-3' was synthesized by a variation of the post-oligomerization method described for the preparation of monoadducts of butadiene epoxides (55, 62). The concentrations of the single-stranded oligonucleotides were determined from their calculated extinction coefficients at 260 nm (63). The modified oligodeoxynucleotide and its complement were annealed in a buffer consisting of 10 mM NaH2PO4, 0.1 M NaCl, and 50 µM Na2EDTA at pH 7.0. The modified duplex was eluted from DNA Grade Biogel hydroxylapatite (Bio-Rad Laboratories, Hercules, CA) with a gradient from 10 to 200 mM NaH2PO4, pH 7.0. It was desalted using Sephadex G-25.
Capillary gel electrophoresis
The purity of the modified duplex was analyzed using a PACE 5500 (Beckman Instruments, Inc., Fullerton, CA) instrument. Electrophoresis was conducted using an eCAP ssDNA 100-R kit applying 12,000 V for 30 min. The electropherogram was monitored at 254 nm.
Mass Spectrometry
MALDI-TOF mass spectra were measured on a Voyager-DE (PerSeptive Biosystems, Inc., Foster City, CA) instrument in negative reflector mode. The matrix contained 0.5 M 3-hydroxypicolinic acid and 0.1 M ammonium citrate.
Thermal Melting
Thermal melting of duplex DNA was monitored using UV spectroscopy at 260 nm in a buffer consisting of 1 M NaCl, 10 mM Na2HPO4, 10 mM NaH2PO4, 50 µM Na2EDTA at pH 7.0. Melting temperatures were determined by measuring the absorbance change as a function of temperature; the temperature range was 15° C to 85° C with a 1° C/min increment.
Electrophoretic Mobility
Adducted or unmodified oligodeoxynucleotides were combined individually with excess complement 5’-d(CGCTTCTTGTC). They were phosphorylated with 3.8 units T4 polynucleotide kinase and 20.8 µL of 10 µM ATP at 37 °C in 6 µL 10x DNA kinase buffer (70 mM Tris-HCl, pH 7.6, 10 mM MgCl2, 5 mM dithiothreitol) (pH 7.6) and incubated overnight at 37 °C with an additional 1.9 units of kinase and 10.4 µl of 10 µM ATP. BamH I linker [5’-d(CGGGATCCCG)2-3'] was phosphorylated with 1.9 units T4 polynucleotide kinase in 2 µL of 10x kinase buffer and 10.4 µL of 10 µM ATP and incubated overnight at 37 °C. Fractions of each reaction (BamH I: 0.025 A260units; unmodified: 0.02 A260 units; four carbon linker: 0.04 A260 units) were removed and incubated with T4 DNA ligase (BamH I: 5 units; unmodified: 2 units; four carbon linker: 2 units) in 2 µL of 10x T4 DNA ligase buffer (50 mM Tris-HCl, 10 mM MgCl2, 10 mM dithiothreitol, 1 mM ATP, 5 µg/mL bovine serum albumin) (pH 7.8) and 10 µL of 10 µM ATP overnight at 16 °C, and precipitated with absolute ethanol. They were suspended in 6 mL of nondenaturing loading buffer (Sigma). 1 µL of a pBR322 Hae III digest (0.4 µg/mL, 10 mM Tris-HCl, 0.1 mM Na2EDTA) (pH 8.0) was mixed with nondenaturing loading buffer per each length marker lane. Electrophoresis was performed using a nondenaturing 8% polyacrylamide gel (mono:bis-acrylamide ratio 29:1, 3.3% catalyst). Gels were run at 1000 V for 2.5-3 h and stained for 30 min with 250 mL GelStar nucleic acid stain (10,000 x) (Biowhittaker Molecular Applications, Walkersville, Maine) in 250 mL 1 × TBE. Gels were imaged on a UV transilluminator (Alpha Innotech, San Leandro, CA). Control multimers formed by ligation of the 10-bp BamH I linker were used to calculate apparent lengths of crosslinked multimers.
NMR
The modified duplex was prepared at a concentration of 2 mM. For observation of nonexchangeable protons, the sample was dissolved in 0.5 mL of 99.96% D2O containing 10 mM NaH2PO4, 0.1 M NaCl, and 50 µM Na2EDTA (pH 7.0). For observation of exchangeable protons, the sample was dissolved in 0.5 mL of 9:1 H2O:D2O in the same buffer. 1H NMR spectra were recorded at 600.13 MHz and 800.23 MHz. The non-exchangeable protons were monitored at 25 °C; the exchangeable protons were monitored at 17 °C. Chemical shifts were referenced to water. Data were processed using the program FELIX2000 (Accelyris, Inc., San Diego, CA). NOESY spectra of non-exchangeable protons were recorded using TPPI phase cycling with mixing times of 150, 200, and 250 ms. Spectra for exchangeable protons were recorded using a 150 ms mixing time. These were recorded with 1024 real data points in the d1 dimension and 2048 real data points in the d2 dimension. A relaxation delay of 2.0 s was used. Water suppression was performed using the WATERGATE sequence (64). TOCSY experiments were performed with mixing times of 90 and 150 ms, utilizing homonuclear Hartman-Hahn transfer with the MLEV17 sequence (65) for mixing. DQF-COSY spectra were zero-filled to give a matrix of 1024 × 2048 real points. A skewed sine-bell square apodization function with a 90° phase shift and a skew factor of 1.0 was used in both dimensions.
Experimental Restraints
(a) Distance Restraints
Footprints were drawn around cross peaks obtained at a mixing time of 200 ms using FELIX2000. Identical footprints were transferred and fit to the crosspeaks obtained at the other two mixing times. The intensities of cross peaks were determined by volume integrations. These were combined as necessary with intensities generated from complete relaxation matrix analysis of a starting DNA structure to generate a hybrid intensity matrix (66, 67). MARDIGRAS (68–70) was used to iteratively refine the hybrid intensity matrix and to optimize the agreement between the calculated and experimental NOE intensities. Calculations were initated using isotropic correlation times of 2, 3, and 4 ns, and with both IniA and IniB starting structures and the three mixing times, yielding eighteen sets of distances. Analysis of this data yielded the experimental distance restraints used in subsequent restrained molecular dynamics calculations, and the corresponding standard deviations for the distance restraints. The distance restraints were divided into five classes, reflecting the confidence level in the experimental data.
(b) Torsion Angle Restraints
Deoxyribose pseudorotation (57) was determined graphically using the sums of 3J 1H coupling constants (58), measured from DQF-COSY spectra. Discrete J1' 2" and J1'2' couplings were measured from active and passive couplings, respectively, of the H2” (d2) to H1' (d1) spectral region. The data were fit to curves relating the coupling constants to the deoxyribose sugar pseudo rotation angle (P), sugar pucker amplitude (φ), and the percentage S-type conformation. The sugar pseudo rotation angle and amplitude ranges were converted to the five dihedral angles ν0to ν4. Coupling constants measured from 1H-31P HMBC spectra were applied (71, 72 1991 1991) to the Karplus relationship (73) to determine the backbone dihedral angle ε (C4'-C3'-O3'-P), related to the H3'-C3'-O3'-P angle by a 120° shift. The ζ (C3'-O3'-P-O5') backbone angles were calculated from the correlation between ε and ζ in B-DNA (60).
Restrained Molecular Dynamics Calculations
Classical A-DNA and B-DNA were used as reference structures to create starting structures for the refinement (74). The butadiene adduct was constructed at A6 using the BUILDER module of INSIGHT II (Accelrys, Inc., San Diego, CA). A-form and B-form structures of the appropriate sequence were energy-minimized by the conjugate gradients method for 200 iterations using the AMBER 7.0 force field (75) without experimental restraints to give starting IniA and IniB used for the subsequent relaxation matrix analysis and molecular dynamics calculations. The restraint energy function included terms describing distances and dihedral restraints as square-well potentials (76). Bond lengths involving hydrogens were fixed with the SHAKE algorithm (77). The generalized Born approach was used to model solvent (78, 79). The calculations utilized a salt concentration of 0.2 mM. A series of randomly seeded rMD calculations were performed over a time course of 40 ps. These used the SANDER module of AMBER 7.0, and the Cornell et al. force field (80), including the Parm94.dat parameter set. The simulated annealing protocol utilized a starting temperature of 25 K. In the first ps the temperature was increased to 600 K. This was maintained for 4 ps, followed by cooling to 298 K over 15 ps. During the final 20 ps the temperature was reduced to 0 K. Temperature was controlled by coupling to a temperature bath. During the first 1 ps of heating a coupling of 0.4 ps was used. During the next 4 ps of constant temperature dynamics a coupling of 1.0 ps was used. In the first 15 ps of cooling, a value of 1.0 ps was used, followed by a value 10 of 0.5 ps for the second 15 ps. During the final 5 ps of cooling, the coupling was ramped down to 0.01 ps. In the first 1 ps of heating, the experimental force constants were amplified by factors that ranged from 0.5 to 1.00. During the 4 ps of constant temperature dynamics and the first 15 ps of cooling, the amplification factor was increased to 1.75. In the final 20 ps of cooling, the amplification factor was reduced to 1.0. Structure coordinates were archived every 0.1 ps over the final 10 ps of the simulation. Structure coordinates extracted from the final 4 ps were averaged and energy-minimized for 200 iterations using the conjugate gradients algorithm. An average structure was obtained from eight randomly seeded rMD calculations. Back-calculation of 1H NOE data was performed using CORMA (v. 4.0) (66, 67). Helicodial parameters were examined using 3DNA (81).
RESULTS
Sample Properties
The purity of the (R,R) N6,N6-dA crosslinked adduct duplex was assessed using capillary gel electrophoresis. The electropherogram exhibited two peaks in a 1:1 ratio after correction for the respective absorbance coefficients. The identity of the duplex was verified using MALDI-TOF mass spectrometry. Mass measurement showed two signals that corresponded to mass units of 3484 and 3272. These peaks corresponded to the crosslinked adduct strand 5'-d(CGGACXYGAAG)-3' and to the complementary strand 5'- d(CTTCTTGTCCG)-3', respectively. The melting temperature of the sample was determined by UV spectroscopy as 50° C, less than the observed 57° C melting temperature of the unmodified ras61 duplex. The crosslink sample yielded excellent NMR data in the temperature range of 10° C − 25 °C.
DNA 1H Resonance Assignments
(a) Nonexchangeable Protons
The sequential NOEs between the aromatic and anomeric protons are displayed in Figure 1. These were assigned using standard methods (82, 83). There were no breaks observed in connectivity in either the crosslinked strand or the complementary strand. With assignments of the sugar H1' protons in hand, the remainder of the deoxyribose sugar protons were assigned from DQF-COSY spectra. With the exception of several of the H5' and H5" protons, assignments of the sugar protons were made unequivocally. Table S1 in the Supporting Information details the complete non-exchangeable 1H NMR assignments of the crosslinked adduct oligodeoxynucleotide duplex.
Figure 1.
Expanded plots of a NOESY spectrum at a mixing time of 200 ms showing sequential NOE connnectivities from aromatic to anomeric protons of the (R,R)-BD-(61,2-3) crosslinked adduct. A. Nucleotides C1→G11 of the modified strand. B. Nucleotides C12→G22 of the complementary strand.
(b) Exchangeable Protons
An expanded region showing the far downfield region of the 1H NMR spectrum, exhibiting cross-peaks between the hydrogen-bonded imino protons is shown in Figure 2. Sequential assignments of the imino protons from base pairs G2•C21→C5•G18 and X6•T17→A10•T13 were obtained, with a break in connectivity observed between base pairs C5•G18 and X6•T17. The NOE between T13 N3H and T14 N3H was weak. It was not observed at the contour level plotted in Figure 2. This crosspeak was also weak in the ras61 spectrum (84) and presumably reflected the effects of strand fraying and resulting rapid exchange of this proton with solvent. Each of the peaks identified in the cytosine amino region of the 1H NMR spectrum exhibited the anticipated cross peak with the appropriate deoxyguanosine imino proton as expected in Watson-Crick base pairing. With the exception of T16, each thymine N3H proton exhibited an NOE to the corresponding adenine H2 proton in the complementary strand. Cross peaks were observed between T17 N3H and the T16 CH3 and T17 CH3 resonances.
Figure 2.
Expanded plot of a NOESY spectrum at a mixing time of 200 ms showing NOE connectivities for the imino protons for the base pairs from G2•C21 to A10•T13. Note that there is a break in the walk between the imino resonances for base pairs G2•C21 and X6•T17. The resonance observed for base pair X6•T17 is shifted in the spectrum.
(c) Butadiene Protons
The protons of the butadiene crosslink were observed as separate resonances, with spectral line widths comparable to the oligodeoxynucleotide protons (Figure 3). At a mixing time of 200 ms, NOEs were observed between the butadiene crosslink protons. The Hα' proton at 3.51 ppm showed NOEs to Hβ at 4.03 ppm and Hα" at 2.72 ppm. The Hβ proton showed NOEs to Hα' and Hα", along with a weak NOE to Hγ at 3.62 ppm and Hδ' at 3.26 ppm. The Hγ proton showed a weak NOE to Hβ (not observed in Figure 3) along with NOEs to Hδ' at 3.01 ppm and Hδ", respectively. A cross peak was observed between T17 N3H and the Hδ ' proton of the crosslink (Figure 4). This was the only cross peak observed between the butadiene crosslink and the oligodeoxynucleotide.
Figure 3.
Expanded NOESY spectrum at 200 ms mixing time exhibiting the assignment of crosslink protons in the (R,R)-BD-(61,2-3) crosslinked adduct duplex. The experiment was at 800.23 MHz and 25 °C.
Figure 4.
NOE observed between T16 N3H and the Hδ’ proton of the (R,R)-BD-(61,2-3) crosslinked adduct. The experiment was at 800.23 MHz and 17 °C.
Torsion Angle Measurements
Analysis of DQF-COSY data suggested that all deoxyribose pseudorotation angles remained in the C2'-endo range anticipated for B-family DNA. The glycosyl torsion angles were monitored using 1H NOESY experiments. These revealed weak NOEs between the purine H8 or pyrimidine H6 protons and the anomeric H1' protons of the attached deoxyribose sugars, consistent with glycosyl torsion angles in the normal anti conformational range. There were also no unusual chemical shifts or 3J1H-31P couplings observed in the 31P spectrum. Data obtained from 3J1H-31P experiments indicated that the torsion angles associated with the backbone phosphodiester linkages were not significantly perturbed by the presence of the crosslink. Karplus analysis yielded values within the standard ranges of 165.0° ± 10° and 235° ± 10° for the backbone torsion angles ε and ζ, respectively (85).
Chemical Shift Effects
The 1H chemical shifts of the crosslinked duplex were compared to those of the unmodified ras61 oligomer (84). Figure 5 shows that chemical shift differences were localized in the crosslinked strand at the two crosslinked nucleotides X6 and Y7. The X6 H1' resonance shifted 0.6 ppm upfield, while the Y7 H8 resonance shifted 0.4 ppm downfield. In the far downfield region of the 1H spectrum, the T17 N3H imino resonance shifted upfield approximately 1.0 ppm. The complementary strand did not exhibit significant changes in 1H chemical shifts.
Figure 5.
Chemical shift differences of protons of the (R,R)-BD-(61,2-3) crosslinked adduct duplex relative to the unmodified ras61 oligodeoxynucleotide. A. The modified strand of the crosslinked adduct. B. The complementary strand of the crosslinked adduct. Grey bars represent the deoxyribose H1' protons; black bars represent the purine H8 or pyrimidine H6 protons, respectively.
Structural Refinement
The structural refinement incorporated 338 experimental distance restraints. There was one NOE observed between the crosslinked butadiene moiety and the DNA. The distance restraints were evenly distributed over the length of the crosslinked oligodeoxynucleotide. In addition, 80 deoxyribose pseudorotation restraints were included. There were 106 phosphodiester backbone torsion angle restraints. The phosphodiester backbone angles ε and ζ were restrained at angles of 165° ± 10° and 245° ± 10° respectively. Empirical Watson-Crick hydrogen-bonding restraints were used for all base pairs except for X6•T17, as NMR data indicated no base pairing at this site. Inspection of the structures that emerged from an initial series of randomly seeded rMD calculations suggested that the Cβ hydroxyl of the crosslink and T17 O4 were within hydrogen bonding distance. It was therefore decided to add an empirical restraint for this hydrogen bond in subsequent calculations.
A stereoview of six energy minimized structures emergent from the rMD calculations is shown in Figure 6. These rMD calculations were initiated from both the A-form and B-form starting structures. These two starting structures exhibited an rmsd of 5.92 Å. The rMD calculations converged to similar ensembles of structures irrespective of starting structure. The maximum pairwise rmsd between these emergent structures was 0.90 Å, suggesting that the experimental distance and torsion angle restraints, combined with the additional empirical hydrogen bonding restraints, enabled the rMD calculations to converge to a well-defined set of structures. The average structure emergent from the rMD calculations exhibited a rmsd of 2.50 Å as compared to the IniB starting structure. This deviation from canonical B-form DNA resulted primarily from structural variation associated with the crosslinked base pairs X6•T17 and Y7•T16.
Figure 6.
A stereoview of six superimposed structures emergent from the simulated annealing rMD protocol; the structures resulted from randomly seeded calculations.
The validities of the structures emergent from the rMD calculations were evaluated using complete relaxation matrix calculations (66, 67). Figure 7 shows R1x values as a function of nucleotide position. The residual values were consistent over the length of the modified oligodeoxynucleotide and ranged from 3.1−14.8 × 10−2. The inclusion of the empirical hydrogen bonding restraint between the Cβ hydroxyl of the crosslinked adduct and T17 O4 resulted in a 10% improvement in the R1x residual for base step C5→X6, as compared to the corresponding calculations in which this empirical restraint was not utilized.
Figure 7.
R1x values as a function of position in the (R,R)-BD-(61,2-3) crosslinked adduct. A. The crosslinked strand. B. The complementary strand.
Structure of the (R,R)-BD-(61-2, 3) Crosslinked Adduct
The structures that emerged from the rMD calculations indicated that the N6,N6-dA butadiene crosslink oriented in the major groove of the DNA, as shown in Figure 8. Watson Crick base pairing was disrupted at X6•T17. In contrast, base pairing at Y7•T16 was maintained. Helicoidal analysis (81) suggested a change of the phosphdiester backbone torsion angle β P5'-O5'-C5'-C4', at X6. In the presence of the N6,N6-dA crosslink, angle β at X6 increased to approximately 200°, as compared to the expected range of 165–180°. The emergent structures suggested the formation of a hydrogen bond between the Cβ-hydroxyl of the butadiene crosslink and T17 O4, thus stabilizing nucleotide T17 in the complementary strand in the absence of Watson-Crick hydrogen bonding with crosslinked nucleotide X6.
Figure 8.
A close up view of the (R,R)-BD-(61,2-3) crosslinked duplex. View from the major groove of X6•T17 and Y7•T16 and the flanking base pairs C5•G18 and G8•C15. The duplex DNA is shown in blue, the crosslink is in red.
The structures that emerged from the rMD calculations suggested that the four-carbon N6,N6-dA crosslink did not bend the DNA duplex. To confirm this observation, a series of electrophoretic mobility assays were conducted on ligated multimers of an oligodeoxynucleotide containing the non-hydroxylated analog of the N6,N6-dA crosslink. Thermal melting studies monitored by UV spectroscopy indicated that the non-hydroxylated alkyl tether also lowered the Tm of the duplex by approximately 6°, as observed for the hydroxylated N6,N6-dA crosslink, suggesting that the non-hydroxylated alkyl tether provided a reasonable model for the N6,N6-dA crosslinked oligodeoxynucleotide studied by NMR. The mobilities of the ligated crosslinked multimers were analyzed by non-denaturing polyacrylamide gel electrophoresis (86). The electrophoretic migration data corroborated NMR data suggesting that this crosslinked oligodeoxynucleotide did not undergo significant bending.
The base stacking patterns at the crosslink site are shown in Figure 9. Helicoidal analysis suggested a decrease in the base pair opening parameter at base pair X6•T17, from the expected range of 0 ± 5° (base pair closed) to a value of approximately −13°. Intrastrand crosslink formation was accompanied by a decrease in the twist angle between base pairs C5•G18 and X6•T17, resulting in unwinding of the duplex. Consequently, in the crosslinked structure, nucleotides X6 and Y7 did not exhibit the typical 36° twist as was observed for the monodentate butadiene triol adduct located at position X6, or for the unmodified ras61 oligodeoxynucleotide. The opening of the duplex at X6•T17 resulted in the six-carbon pyrimidine ring of the X6 purine stacking above the imidazole ring of the Y7 purine. In the complementary strand, the base stacking of the T16 and T17 nucleobases appeared unperturbed by the presence of the N6,N6-dA crosslink.
Figure 9.
Base stacking orientations of the (R,R)-BD-(61,2-3) crosslinked duplex. A. The crosslinked duplex detailing base stacking of the X6 and Y7 base pairs. B. The crosslinked duplex detailing base stacking of the X6 and A7 base pairs. C. The unmodified ras61 oligodeoxynucleotide duplex detailing base stacking of the A6 and A7 base pairs.
DISCUSSION
The genotoxicity of butadiene may be related to its ability to form crosslinks in DNA via its diepoxide oxidation product. Animal studies revealed species differences between mice and rats with regard to BD genotoxicity, which mice exhibiting greater sensitivity (7, 8, 87). This was explained by the observation that in mice the conversion of BD to BDO2 was more efficient than in rats, an observation which also pointed to BDO2 as the key proximate electrophile in BD-mediated genotoxicity (45). This suspicion was confirmed by studies showing that BDO2 was indeed considerably more mutagenic than the mono-epoxide EB (37)—probably due to its crosslinking ability. The primary evidence suggesting the presence of DBO2-induced DNA crosslinks in vivo comes from studies in which human lymphoblastoid TK6 and splenic T cells were exposed to low levels of BDO2 (37, 88, 89). These experiments revealed transitions and transversions at both GC and AT sites, suggesting the presence of both dG and dA adducts arising from BDO2. They also revealed the presence of significant levels of deletion mutants, consistent with the presence of DNA crosslinks.
Structural Perturbations Associated with the N6,N6-dA Intrastrand Crosslink
This intrastrand crosslink, tethering nucleotides X6 and Y7 in the ras61 oligodeoxynucleotide, oriented in the major groove. That there were no interruptions in DNA sequential NOE connectivities (Figure 1), and all Watson-Crick base pairs, with the exception of base pair X6•T17, were intact (Figure 2), suggesting that the crosslink did not substantially perturb the right-handed DNA helix. Bending of the intrastrand crosslinked duplex was not observed. This was consistent with the fact that the major groove of B-family DNA had capacity to accommodate the four-carbon crosslink. One NOE was observed between the (R,R) N6,N6-dA crosslinked adduct and the DNA, an observation which was consistent with the major groove orientation of the adduct, since the major groove contains few protons as potential sources of dipolar relaxation with the BD protons. An approximate 1 ppm upfield shift of the T17 N3H imino proton resonance was consistent with a loss of hydrogen bonding and supported the conclusion that Watson-Crick base-pairing was disrupted at base pair X6•T17. The formation of a hydrogen bond between the β-OH group of the crosslink and T17 O4, predicted by the rMD calculations, possibly explained the observation of the T17 N3H resonance. It suggested that in the crosslinked adduct, this non-hydrogen bonded proton was sheltered from fast exchange with the solvent. The rMD calculations predicted that the crosslinked duplex was characterized by an increase in the β torsion angle at X6. This facilitated opening of the duplex and enabled an approximate 5° unwinding of the duplex at base pair X6•T17. The resulting changes in stacking between crosslinked nucleotides X6 and Y7 possibly accounted for the upfield shift of the Y7 H8 resonance (Figure 5).
Mechanistic Insights into Formation of N6,N6-dA Intrastrand Crosslinks
This N6,N6-dA crosslinked adduct has not yet been reported from mass spectrometry analysis of DNA exposed to BDO2 (49, 54). It is generally argued that N6-dA alkylation products of butadiene oxides arise not by direct attack at the exocyclic amine, but rather by initial alkylation at the more nucleophilic N1 imine, followed by Dimroth rearrangement to yield the N6-dA product (50, 51, 90). One might predict that formation of an intrastrand N6,N6-dA crosslink would require tandem N1-dA alkylation by BDO2 at the neighboring adenines, followed by tandem Dimroth rearrangements of both alkylated dA nucleotides. Alternatively, formation of a X6 N1-dA adduct by BDO2, followed by Dimroth rearrangement, would result in a N6-dA BDO adduct (91, 92). Orientation of the X6 N6-dA BDO adduct similar to N6-dA butadiene triol adducts (93, 94) might facilitate direct attack on the BDO epoxide by the less nucleophilic N6-dA at the neighboring A7. To examine this possibility, the N6-dA BDO adduct was modeled at position X6 based upon the experimentally determined solution structures of the corresponding N6-dA BDT adducts (93, 94). The modeling study (Figure 10) suggested that this might be a reasonable hypothesis. However, the initially formed N1-monoalkylated intermediate might also reorient about the glycosyl bond, into the syn conformation. Although this has not been confirmed for the N1-dA monoalkylation product of BD, the N1-(1-hydroxy-3-buten-2(S)-yl)-2'-deoxyinosine adduct arising from deamination following N1-dA alkylation at N1-dA by BDO was accommodated in duplex DNA by rotation about the glycosyl torsion angle into the syn conformation (58). Overall, formation of the N6,N6-dA intrastrand crosslink seems likely to represent a rare event, with hydrolysis of the monoalkylated BDO intermediates prevailing. Indeed, the BDT N1-dA adduct was identified in humans exposed occupationally to BD (52). The N6-dA BDT adduct was identified in Chinese Hamster ovary cells (53).
Figure 10.
Molecular modeling of the N6-dA BDO adduct at position X6 of the ras61 oligodeoxynucleotide. The X6 BDO adduct is predicted to orient in the 3'-direction, toward the exocyclic amino group of A7. This might faciliate direct attack by the exocyclic amine on the epoxide, leading to formation of an N6,N6-dA crosslink. Only nucleotides X6 and A7 in the modified strand of the duplex DNA are shown. The BD moiety is in red; the DNA is in blue.
Structure-Activity Relationships
The major groove orientation and the small conformational perturbation of the DNA structure induced by the crosslink are possibly correlated with facile bypass of this lesion by a variety of DNA polymerases. It was of interest to compare this crosslink structure with those of two N6-dA butadiene triol adducts, which are products of monoalkylation at N6-dA by BD (93, 94). The monoalkylated N6-dA BDT adducts also did not pose blocks to replication (56). Perhaps significantly, the R(61,2) and both the R-and S(61,3) N6-dA α adducts of styrene oxide also did not pose blocks to replication (59, 60), and also oriented in the major groove (95–97). The R- and S(61,2) β adducts of styrene oxide behaved similarly (60, 97). Collectively, these results fit an emerging pattern in which lesion bypass by DNA polymerases is minimally affected by the presence of small major groove N6-dA adducts, although it should be noted that the R(61,2) α adduct of styrene oxide did block replication (59). In contrast, the (R,R) and (S,S) N2,N2-dG intrastrand crosslinks were severe replication blocks when examined in vitro (61).
The (R,R) N6,N6-dA intrastrand crosslink was significantly more mutagenic than two N6-dA BDT mono adducts previously examined as to mutagenesis (56) and structure (93, 94). In the mammalian COS-7 site-specific mutagenesis assay the most frequent mutations were A→G transitions, followed by A→C and A→T transversions, located at the 3'-adducted dA in the tandem crosslink. In Escherichia coli wild type and AB2480 (uvrA-, recA-) cells the (R,R) N6,N6-dA crosslink was significantly less mutagenic, yielding A→G transitions (55). Recent data suggests that in E. coli, DNA polymerase II is responsible for the mutagenic bypass of the (R,R) N6,N6-dA crosslink (58).
The observation of A→G transitions at the 3'-position of the tandem crosslink suggested that this (R,R) N6,N6-dA crosslink facilitated incorrect incorporation of dCTP opposite crosslinked nucleotide Y7. It will be of interest to examine the structure of a mismatched dC opposite the crosslink. NMR studies on mismatched dC opposite the S(61,2) α adduct of styrene oxide (98), which induced low levels of A→G mutations (59), and opposite the R-and S(61,3) α adducts of styrene oxide (99) which were non-mutagenic (59), revealed both sequence- and stereospecific differences in the mismatched duplexes.
The corresponding (S,S) N6,N6-dA crosslink was less mutagenic in the COS-7 system (55, 61). This may predict stereospecific structural differences between the (R,R) and (S,S) N6,N6-dA crosslinks, and it will be of interest to compare the structure of the (S,S) N6,N6-dA crosslink with that of the (R,R) N6,N6-dA crosslink.
Biological Significance
When B6c3F1 lacI transgenic mice were exposed to butadiene, the primary adenine-specific point mutations were A→T transversions (100–104). The site specific mutagenesis experiments on the (R,R) N6,N6-dA intrastrand crosslink, yielding primarily A→G mutations (55) suggest that it does not represent the source of the predominant A→T BD-induced mutations in bacterial or in mammalian cells. Nonetheless, butadiene was reported to induce A→G transitions in the H-ras codon 61 (105). The (R,R) N6,N6-dA crosslink may contribute to these. The N1-deoxyinosine adduct represents another potential source of A→G transitions. This adduct arises from deamination of the initially formed N1-dA adduct, and is strongly mutagenic with respect to A→G transitions (55). The adducts responsible for BD-induced A→T transversions (100–104) remain to be determined. BD-induced crosslinks involving monoalkylation of N7-dG (106–109) followed by crosslinking with dA (49) represent potential candidates.
The major BDO2-induced DNA crosslink is the N7,N7-dG interstrand crosslink (41). It occurs in 5'-GNC-3' sequences (40), as opposed to nearest neighbor 5'-GC-3' sequences. In this regard, BDO2-induced N7,N7-dG interstrand crosslinking appears to be similar to that of the nitrogen mustard mechlorethamine (110). It will be of considerable interest to examine structures of N7,N7-dG interstrand crosslinks.
Summary
The intrastrand (R,R) N6,N6-dA crosslink induced by BDO2 in duplex DNA oriented in the major groove of the duplex. It resulted in an increase in base pair opening at base pair X6•T17, accompanied by a shift in the phosphodiester backbone torsion angle β at nucleotide X6. The DNA helix was not bent by the presence of the four-carbon crosslink. A hydrogen bond between the hydroxyl group located on the β-carbon of the four-carbon crosslink, and T17 O4 perhaps stabilized base pair opening at X6•T17 and protected the T17 imino proton from solvent exchange. The opening of base pair X6•T17 altered base stacking and induced unwinding of the duplex.
Supplementary Material
The Supporting Information contains Table S1, showing the 1H chemical shift assignments for the ras61 (R,R) N6,N6-dA crosslink, Table S2, showing the NOE restraints utilized in the rMD calculations for the (R,R) N6,N6-dA crosslink, and Figure S1, showing force field parameters for the (R,R) N6,N6-dA crosslink. This material is available free of charge via the Internet at http://pubs.acs.org.
Scheme 2.
The ras61 oligodeoxynucleotide (A), and the chemical structure of (B) the (2R,3R)-N6-(2,3-dihydroxybutyl)-2-deoxyadenosyl cross link adduct and nomenclature.
Table 1.
Analysis of the rMD-Generated Structures of the ras61 (R,R) N6,N6-dA crosslinked adduct.
| NMR restraints | |
| total no. of distance restraints | 338 |
| interresidue distance restraints | 91 |
| intraresidue distance restraints | 247 |
| DNA-crosslink distance restraints | 0 |
| torsion angle restraints | |
| sugar pucker restraints | 80 |
| backbone torsion angle restraints | 71 |
| empirical restraints | |
| H-bonding restraints | 46 |
| dihedral planarity restraints (in XPLOR) | 20 |
| structural statistics | |
| NMR R-factor (R1x)a,b,c | 1.12 ×10−1 |
| rmsd of NOE violations (Å) | 2.15 ×10−2 |
| no. of NOE violations > 0.15 Å | 9 |
| pairwise rmsd (Å) over all atoms | |
| IniA vs. IniB | 5.92 |
| IniA vs. rMDAavg | 4.75 |
| IniB vs. rMDBavg | 2.50 |
| rMDA vs rMDB | 0.90 |
| rMDA vs rMDA | 0.51 |
| rMDB vs rMDB | 0.81 |
| <rMDA> vs. rMDAavg | 0.33 ± 0.11 |
| <rMDB> vs. rMDBavg | 0.52 ± 0.21 |
The mixing time was 150 ms.
R1x = ∑|(ao)i1/6 − (ac)i1/6|/∑|(ao)i1/6|, where ao and ac are the intensities of observed (non-zero) and calculated NOE cross-preaks.
<rMDA>, represents a group of six converged structures starting from IniA; <rMDB>, represents a group of six converged structures starting from IniB. rMDAavg represents the potential energy minimized average structure of all six rMD calculations starting with A-form DNA rMDBavg represents the potential energy minimized average structure of all eight rMD calculations starting with B-form DNA. The comparisons: rMDA vs rMDB, rMDA vs rMDA, rMDB vs. rMDB, represent the maximum observed pairwise rmsd over all atoms between these groups.
ACKNOWLEDGEMENTS
We acknowledge the contributions of Mr. Markus Voehler, and Dr. Jaison Jacob, who assisted with NMR spectroscopy. Dr. Jarrod Smith assisted with structural refinement. Dr. J. R. Carmical (The University of Texas Medical Branch, Galveston) provided helpful discussions.
Footnotes
This work was supported by NIH grants ES-05509 and ES-05355 (M.P.S.). Funding for the NMR spectrometers was supplied by Vanderbilt University; by NIH grant RR-05805, and the Vanderbilt Center in Molecular Toxicology, ES-00267. The Vanderbilt-Ingram Cancer Center is supported by NIH grant CA-68485.
Abbreviations: BD, butadiene; BDE, 3,4-epoxy-1,2-butanediol; BDO, butadiene monoepoxide (1,2-epoxy-3-butene); BDO2, butadiene diepoxide (1,2:3,4-diepoxybutane); BDT; butadiene triol; CPK, Corey-Pauling-Koltun space-filling models; DQF-COSY, double-quantum filtered correlation spectroscopy; HMBC, heteronuclear multiple bond correlation spectroscopy; HMVK, hydroxymethylvinylketone; MALDI-TOF, matrix assisted laser desorption ionization time-off-light mass spectrometry; NOE, nuclear Overhauser enhancement; NOESY, nuclear Overhauser enhancement spectroscopy; R1x, sixth root residual; rMD, restrained molecular dynamics; rmsd, root mean square deviation; SBR, styrene-butadiene rubber; TBE, tris borate EDTA buffer; TOCSY, total correlation spectroscopy; TPPI, time-proportional phase increment.
The definitions of the prochiral protons at Cα and Cδ of the N6,N6-dA crosslink moiety are based upon the Cahn, Ingold, and Prelog nomenclature. The proton Hα is defined as the pro-R proton at Cα; Hα' is defined as the pro-S proton at Cα. Likewise, Hδ is the pro-R proton at Cα; Hδ' is the pro-S proton at Cδ.
REFERENCES
- 1.Himmelstein MW, Acquavella JF, Recio L, Medinsky MA, Bond JA. Toxicology and epidemiology of 1,3-butadiene. Crit. Rev. Toxicol. 1997;27:1–108. doi: 10.3109/10408449709037482. [DOI] [PubMed] [Google Scholar]
- 2.Jackson MA, Stack HF, Rice JM, Waters MD. A review of the genetic and related effects of 1,3-butadiene in rodents and humans. Mutat. Res. 2000;463:181–213. doi: 10.1016/s1383-5742(00)00056-9. [DOI] [PubMed] [Google Scholar]
- 3.Pelz N, Dempster NM, Shore PR. Analysis of low molecular weight hydrocarbons including 1,3-butadiene in engine exhaust gases using an aluminum oxide porous-layer open-tubular fused-silica column. J. Chromatogr. Sci. 1990;28:230–235. doi: 10.1093/chromsci/28.5.230. [DOI] [PubMed] [Google Scholar]
- 4.Brunnemann KD, Kagan MR, Cox JE, Hoffmann D. Analysis of 1,3-butadiene and other selected gas-phase components in cigarette mainstream and sidestream smoke by gas chromatography-mass selective detection. Carcinogenesis. 1990;11:1863–1868. doi: 10.1093/carcin/11.10.1863. [DOI] [PubMed] [Google Scholar]
- 5.Huff JE, Melnick RL, Solleveld HA, Haseman JK, Powers M, Miller RA. Multiple organ carcinogenicity of 1,3-butadiene in B6c3F1 mice after 60 weeks of inhalation exposure. Science. 1985;227:548–549. doi: 10.1126/science.3966163. [DOI] [PubMed] [Google Scholar]
- 6.Melnick RL, Huff J, Chou BJ, Miller RA. Carcinogenicity of 1,3-butadiene in C57BL/6 x C3H F1 mice at low exposure concentrations. Cancer Res. 1990;50:6592–6599. [PubMed] [Google Scholar]
- 7.Melnick RL, Huff JE, Roycroft JH, Chou BJ, Miller RA. Inhalation toxicology and carcinogenicity of 1,3-butadiene in B6c3F1 mice following 65 weeks of exposure. Environ. Health Perspect. 1990;86:27–36. doi: 10.1289/ehp.908627. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Owen PE, Glaister JR. Inhalation toxicity and carcinogenicity of 1,3-butadiene in Sprague-Dawley rats. Environ Health Perspect. 1990;86:19–25. doi: 10.1289/ehp.908619. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.United States Environmental Protection Agency. 1,3-Butadiene. Carcinogenicity assessment for lifetime exposure: Weight-of-evidence characterization. 2002 Available at http://www.epa.gov/iris/subst/0139.htm.
- 10.International Agency for Research on Cancer. Re-evaluation of some organic chemicals, hydrazine and hydrogen peroxide, IRC Monographs on the Evaluation of Carcinogenic Risks to Humans. IARC Sci. Publ. 1999;71:109–125. [PMC free article] [PubMed] [Google Scholar]
- 11.Bird MG, Rice JM, Bond JA. Evaluation of 1,3-butadiene, isoprene and chloroprene health risks. Chem. Biol. Interact. 2001;135–136:1–17. doi: 10.1016/s0009-2797(01)00233-2. [DOI] [PubMed] [Google Scholar]
- 12.Rice JM, Boffetta P. 1,3-Butadiene, isoprene and chloroprene: Reviews by the IARC monographs programme, outstanding issues, and research priorities in epidemiology. Chem. Biol. Interact. 2001;135–136:11–26. doi: 10.1016/s0009-2797(01)00175-2. [DOI] [PubMed] [Google Scholar]
- 13.Ward JB, Jr., Ammenheuser MM, Bechtold WE, Whorton EB, Jr., Legator MS. Hprt mutant lymphocyte frequencies in workers at a 1,3-butadiene production plant. Environ. Health Perspect. 1994;102 Suppl 9:79–85. doi: 10.1289/ehp.94102s979. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Ward JB, Jr., Ammenheuser MM, Whorton EB, Jr., Bechtold WE, Kelsey KT, Legator MS. Biological monitoring for mutagenic effects of occupational exposure to butadiene. Toxicology. 1996;113:84–90. doi: 10.1016/0300-483x(96)03431-2. [DOI] [PubMed] [Google Scholar]
- 15.Sram RJ, Rossner P, Peltonen K, Podrazilova K, Mrackova G, Demopoulos NA, Stephanou G, Vlachodimitropoulos D, Darroudi F, Tates AD. Chromosomal aberrations, sister-chromatid exchanges, cells with high frequency of SCE, micronuclei and comet assay parameters in 1,3-butadiene-exposed workers. Mutat. Res. 1998;419:145–154. doi: 10.1016/s1383-5718(98)00135-1. [DOI] [PubMed] [Google Scholar]
- 16.Delzell E, Sathiakumar N, Hovinga M, Macaluso M, Julian J, Larson R, Cole P, Muir DC. A follow-up study of synthetic rubber workers. Toxicology. 1996;113:182–189. doi: 10.1016/0300-483x(96)03443-9. [DOI] [PubMed] [Google Scholar]
- 17.Meinhardt TJ, Lemen RA, Crandall MS, Young RJ. Environmental epidemiologic investigation of the styrene-butadiene rubber industry. Mortality patterns with discussion of the hematopoietic and lymphatic malignancies. Scand. J. Work Environ. Health. 1982;8:250–259. doi: 10.5271/sjweh.2469. [DOI] [PubMed] [Google Scholar]
- 18.Matanoski G, Francis M, Correa-Villasenor A, Elliott E, Santos-Burgoa C, Schwartz L. Cancer epidemiology among styrene-butadiene rubber workers. IARC Sci. Publ. 1993;127:363–374. [PubMed] [Google Scholar]
- 19.Santos-Burgoa C, Matanoski GM, Zeger S, Schwartz L. Lymphohematopoietic cancer in styrene-butadiene polymerization workers [see comments] Am. J. Epidemiol. 1992;136:843–854. doi: 10.1093/aje/136.7.843. [DOI] [PubMed] [Google Scholar]
- 20.Macaluso M, Larson R, Delzell E, Sathiakumar N, Hovinga M, Julian J, Muir D, Cole P. Leukemia and cumulative exposure to butadiene, styrene and benzene among workers in the synthetic rubber industry. Toxicology. 1996;113:190–202. doi: 10.1016/0300-483x(96)03444-0. [DOI] [PubMed] [Google Scholar]
- 21.Matanoski GM, Schwarts L. Mortality of workers in styrene-butadiene polymer production. J. Occup. Med. 1987;29:675–680. [PubMed] [Google Scholar]
- 22.Santos-Burgoa C, Eden-Wynter RA, Riojas-Rodriguez H, Matanoski GM. Living in a chemical world. Health impact of 1,3-butadiene carcinogenesis. Ann. N. Y. Acad. Sci. 1997;837:176–188. doi: 10.1111/j.1749-6632.1997.tb56874.x. [DOI] [PubMed] [Google Scholar]
- 23.Matanoski G, Elliott E, Tao X, Francis M, Correa-Villasenor A, Santos-Burgoa C. Lymphohematopoietic cancers and butadiene and styrene exposure in synthetic rubber manufacture. Ann. N. Y. Acad. Sci. 1997;837:157–169. doi: 10.1111/j.1749-6632.1997.tb56872.x. [DOI] [PubMed] [Google Scholar]
- 24.Albertini R, Clewell H, Himmelstein MW, Morinello E, Olin S, Preston J, Scarano L, Smith MT, Swenberg J, Tice R, Travis C. The use of non-tumor data in cancer risk assessment: Reflections on butadiene, vinyl chloride, and benzene. Regul. Toxicol. Pharmacol. 2003;37:105–132. doi: 10.1016/s0273-2300(02)00019-3. [DOI] [PubMed] [Google Scholar]
- 25.Csanady GA, Guengerich FP, Bond JA. Comparison of the biotransformation of 1,3-butadiene and its metabolite, butadiene monoepoxide, by hepatic and pulmonary tissues from humans, rats and mice [published erratum appears in Carcinogenesis 1993 Apr;14(4):784] Carcinogenesis. 1992;13:1143–1153. doi: 10.1093/carcin/13.7.1143. [DOI] [PubMed] [Google Scholar]
- 26.Duescher RJ, Elfarra AA. Human liver microsomes are efficient catalysts of 1,3-butadiene oxidation: Evidence for major roles by cytochromes P450 2A6 and 2E1. Arch. Biochem. Biophys. 1994;311:342–349. doi: 10.1006/abbi.1994.1246. [DOI] [PubMed] [Google Scholar]
- 27.Malvoisin E, Evrard E, Roberfroid M, Mercier M. Determination of Kovats retention indices with a capillary column and electron-capture detection: Application to the assay of the enzymatic conversion of 3,4-epoxy-1-butene into diepoxybutane. J. Chromatogr. 1979;186:81–87. doi: 10.1016/s0021-9673(00)95238-5. [DOI] [PubMed] [Google Scholar]
- 28.Seaton MJ, Follansbee MH, Bond JA. Oxidation of 1,2-epoxy-3-butene to 1,2:3,4-diepoxybutane by cDNA-expressed human cytochromes P450 2E1 and 3A4 and human, mouse and rat liver microsomes. Carcinogenesis. 1995;16:2287–2293. doi: 10.1093/carcin/16.10.2287. [DOI] [PubMed] [Google Scholar]
- 29.Malvoisin E, Roberfroid M. Hepatic microsomal metabolism of 1,3-butadiene. Xenobiotica. 1982;12:137–144. doi: 10.3109/00498258209046787. [DOI] [PubMed] [Google Scholar]
- 30.Himmelstein MW, Turner MJ, Asgharian B, Bond JA. Comparison of blood concentrations of 1,3-butadiene and butadiene epoxides in mice and rats exposed to 1,3-butadiene by inhalation. Carcinogenesis. 1994;15:1479–1486. doi: 10.1093/carcin/15.8.1479. [DOI] [PubMed] [Google Scholar]
- 31.Himmelstein MW, Asgharian B, Bond JA. High concentrations of butadiene epoxides in livers and lungs of mice compared to rats exposed to 1,3-butadiene. Toxicol. Appl. Pharmacol. 1995;132:281–288. doi: 10.1006/taap.1995.1109. [DOI] [PubMed] [Google Scholar]
- 32.Cheng X, Ruth JA. A simplified methodology for quantitation of butadiene metabolites. Application to the study of 1,3-butadiene metabolism by rat liver microsomes. Drug. Metab. Dispos. 1993;21:121–124. [PubMed] [Google Scholar]
- 33.Nauhaus SK, Fennell TR, Asgharian B, Bond JA, Sumner SC. Characterization of urinary metabolites from Sprague-Dawley rats and B6c3F1 mice exposed to [1,2,3,4-13C]butadiene. Chem. Res. Toxicol. 1996;9:764–773. doi: 10.1021/tx950196u. [DOI] [PubMed] [Google Scholar]
- 34.Kemper RA, Elfarra AA, Myers SR. Metabolism of 3-butene-1,2-diol in B6c3F1 mice. Evidence for involvement of alcohol dehydrogenase and cytochrome P450. Drug Metab. Dispos. 1998;26:914–920. [PubMed] [Google Scholar]
- 35.Boogaard PJ, Bond JA. The role of hydrolysis in the detoxification of 1,2:3,4-diepoxybutane by human, rat, and mouse liver and lung in vitro. Toxicol. Appl. Pharmacol. 1996;141:617–627. doi: 10.1006/taap.1996.0328. [DOI] [PubMed] [Google Scholar]
- 36.Powley MW, Jayaraj K, Gold A, Ball LM, Swenberg JA. 1,N2-propanodeoxyguanosine adducts of the 1,3-butadiene metabolite, hydroxymethylvinyl ketone. Chem. Res. Toxicol. 2003;16:1448–1454. doi: 10.1021/tx030021h. [DOI] [PubMed] [Google Scholar]
- 37.Cochrane JE, Skopek TR. Mutagenicity of butadiene and its epoxide metabolites: I. Mutagenic potential of 1,2-epoxybutene, 1,2,3,4-diepoxybutane and 3,4-epoxy-1,2-butanediol in cultured human lymphoblasts. Carcinogenesis. 1994;15:713–717. doi: 10.1093/carcin/15.4.713. [DOI] [PubMed] [Google Scholar]
- 38.Brookes P, Lawley PD. The reaction of mono and di-functional alkylating agents with nucleic acids. Biochem. J. 1961;80:496–503. doi: 10.1042/bj0800496. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39.Lawley PD, Brookes P. Interstrand cross-linking of DNA by difunctional alkylating agents. J. Mol. Biol. 1967;25:143–160. doi: 10.1016/0022-2836(67)90285-9. [DOI] [PubMed] [Google Scholar]
- 40.Millard JT, White MM. Diepoxybutane cross-links DNA at 5'-GNC sequences. Biochemistry. 1993;32:2120–2124. doi: 10.1021/bi00059a034. [DOI] [PubMed] [Google Scholar]
- 41.Park S, Tretyakova N. Structural characterization of the major DNA-DNA cross-link of 1,2,3,4-diepoxybutane. Chem. Res. Toxicol. 2004;17:129–136. doi: 10.1021/tx0342058. [DOI] [PubMed] [Google Scholar]
- 42.Vangala RR, Laib RJ, Bolt HM. Evaluation of DNA damage by alkaline elution technique after inhalation exposure of rats and mice to 1,3-butadiene. Arch. Toxicol. 1993;67:34–38. doi: 10.1007/BF02072032. [DOI] [PubMed] [Google Scholar]
- 43.Ristau C, Deutschmann S, Laib RJ, Ottenwalder H. Detection of diepoxybutane-induced DNA-DNA crosslinks by cesium trifluoracetate (CsTFA) density-gradient centrifugation. Arch. Toxicol. 1990;64:343–344. doi: 10.1007/BF01972998. [DOI] [PubMed] [Google Scholar]
- 44.Thornton-Manning JR, Dahl AR, Bechtold WE, Griffith WCJ, Henderson RF. Comparison of the disposition of butadiene epoxides in Sprague-Dawley rats and B6c3F1 mice following a single and repeated exposures to 1,3-butadiene via inhalation. Toxicology. 1997;123:125–134. doi: 10.1016/s0300-483x(97)00112-1. [DOI] [PubMed] [Google Scholar]
- 45.Thornton-Manning JR, Dahl AR, Bechtold WE, Griffith WC, Jr., Henderson RF. Disposition of butadiene monoepoxide and butadiene diepoxide in various tissues of rats and mice following a low-level inhalation exposure to 1,3-butadiene. Carcinogenesis. 1995;16:1723–1731. doi: 10.1093/carcin/16.8.1723. [DOI] [PubMed] [Google Scholar]
- 46.Wickliffe JK, Ammenheuser MM, Salazar JJ, Abdel-Rahman SZ, Hastings-Smith DA, Postlethwait EM, Lloyd RS, Ward JB., Jr. A model of sensitivity: 1,3-butadiene increases mutant frequencies and genomic damage in mice lacking a functional microsomal epoxide hydrolase gene. Environ Mol. Mutagen. 2003;42:106–110. doi: 10.1002/em.10181. [DOI] [PubMed] [Google Scholar]
- 47.Abdel-Rahman SZ, Ammenheuser MM, Ward JB., Jr. Human sensitivity to 1,3-butadiene: Role of microsomal epoxide hydrolase polymorphisms. Carcinogenesis. 2001;22:415–423. doi: 10.1093/carcin/22.3.415. [DOI] [PubMed] [Google Scholar]
- 48.Abdel-Rahman SZ, El-Zein RA, Ammenheuser MM, Yang Z, Stock TH, Morandi M, Ward JB., Jr. Variability in human sensitivity to 1,3-butadiene: Influence of the allelic variants of the microsomal epoxide hydrolase gene. Environ. Mol. Mutagen. 2003;41:140–146. doi: 10.1002/em.10142. [DOI] [PubMed] [Google Scholar]
- 49.Park S, Hodge J, Anderson C, Tretyakova N. Guanine-adenine DNA cross-Linking by 1,2,3,4-diepoxybutane: Potential basis for biological activity. Chem. Res. Toxicol. 2004;17:1638–1651. doi: 10.1021/tx0498206. [DOI] [PubMed] [Google Scholar]
- 50.Qian C, Dipple A. Different mechanisms of aralkylation of adenosine at the 1- and N6- positions. Chem. Res. Toxicol. 1995;8:389–395. doi: 10.1021/tx00045a010. [DOI] [PubMed] [Google Scholar]
- 51.Kim HY, Finneman JI, Harris CM, Harris TM. Studies of the mechanisms of adduction of 2'-deoxyadenosine with styrene oxide and polycyclic aromatic hydrocarbon dihydrodiol epoxides. Chem. Res. Toxicol. 2000;13:625–637. doi: 10.1021/tx000054m. [DOI] [PubMed] [Google Scholar]
- 52.Zhao C, Vodicka P, Sr#m1 RJ, Hemminki K. Human DNA adducts of 1,3-butadiene, an important environmental carcinogen. Carcinogenesis. 2000;21:107–111. doi: 10.1093/carcin/21.1.107. [DOI] [PubMed] [Google Scholar]
- 53.Leuratti C, Jones NJ, Marafante E, Kostiainen R, Peltonen K, Waters R. DNA damage induced by the environmental carcinogen butadiene: identification of a diepoxybutane-adenine adduct and its detection by 32P-postlabelling. Carcinogenesis. 1994;15:1903–1910. doi: 10.1093/carcin/15.9.1903. [DOI] [PubMed] [Google Scholar]
- 54.Tretyakova N, Sangaiah R, Yen TY, Gold A, Swenberg JA. Adenine adducts with diepoxybutane: Isolation and analysis in exposed calf thymus DNA. Chem. Res. Toxicol. 1997;10:1171–1179. doi: 10.1021/tx9700681. [DOI] [PubMed] [Google Scholar]
- 55.Kanuri M, Nechev LV, Tamura PJ, Harris CM, Harris TM, Lloyd RS. Mutagenic spectrum of butadiene-derived N1-deoxyinosine adducts and N6,N6-deoxyadenosine intrastrand cross-links in mammalian cells. Chem. Res. Toxicol. 2002;15:1572–1580. doi: 10.1021/tx025591g. [DOI] [PubMed] [Google Scholar]
- 56.Carmical JR, Nechev LV, Harris CM, Harris TM, Lloyd RS. Mutagenic potential of adenine N6 adducts of monoepoxide and diolepoxide derivatives of butadiene. Environ. Mol. Mutagen. 2000;35:48–56. [PubMed] [Google Scholar]
- 57.Carmical JR, Zhang M, Nechev L, Harris CM, Harris TM, Lloyd RS. Mutagenic potential of guanine N2 adducts of butadiene mono- and diolepoxide [published erratum appears in Chem Res Toxicol 2000 May;13(5):430] Chem. Res. Toxicol. 2000;13:18–25. doi: 10.1021/tx9901332. [DOI] [PubMed] [Google Scholar]
- 58.Kanuri M, Nechev LV, Kiehna SE, Tamura PJ, Harris CM, Harris TM, Lloyd RS. Evidence for Escherichia coli polymerase II mutagenic bypass of intrastrand DNA crosslinks. DNA Repair, submitted for publication. 2005 doi: 10.1016/j.dnarep.2005.08.011. [DOI] [PubMed] [Google Scholar]
- 59.Latham GJ, Zhou L, Harris CM, Harris TM, Lloyd RS. The replication fate of R- and S-styrene oxide adducts on adenine N6 is dependent on both the chirality of the lesion and the local sequence context. J. Biol. Chem. 1993;268:23427–23434. [PubMed] [Google Scholar]
- 60.Kanuri M, Harris CM, Harris TM, Lloyd RS. Efficient non-mutagenic replication bypass of DNAs containing β-styrene oxide N6-adenine adducts. Env. Mol. Mutagen. 2001;38:357–360. doi: 10.1002/em.10030. [DOI] [PubMed] [Google Scholar]
- 61.Carmical JR, Kowalczyk A, Zou Y, Van Houten B, Nechev LV, Harris CM, Harris TM, Lloyd RS. Butadiene-induced intrastrand DNA cross-links: A possible role in deletion mutagenesis. J. Biol. Chem. 2000;275:19482–19489. doi: 10.1074/jbc.M002037200. [DOI] [PubMed] [Google Scholar]
- 62.Nechev LV, Zhang M, Tsarouhtsis D, Tamura PJ, Wilkinson AS, Harris CM, Harris TM. Synthesis and characterization of nucleosides and oligonucleotides bearing adducts of butadiene epoxides on adenine N6 and guanine N2. Chem. Res. Toxicol. 2001;14:379–388. doi: 10.1021/tx000241k. [DOI] [PubMed] [Google Scholar]
- 63.Borer PN. Handbook of Biochemistry and Molecular Biology. Cleveland, OH: CRC Press; 1975. [Google Scholar]
- 64.Piotto M, Saudek V, Sklenar V. Gradient-tailored excitation for single-quantum NMR spectroscopy of aqueous solutions. J. Biomol. NMR. 1992;2:661–665. doi: 10.1007/BF02192855. [DOI] [PubMed] [Google Scholar]
- 65.Bax A, Davis DG. MLEV-17-based two-dimensional homonuclear magnetization transfer spectroscopy. J. Magn. Reson. 1985;65:355–360. [Google Scholar]
- 66.James TL. Relaxation matrix analysis of two-dimensional nuclear Overhauser effect spectra. Curr. Opin. Struct. Biol. 1991;1:1042–1053. [Google Scholar]
- 67.Keepers JW, James TL. A theoretical study of distance determination from NMR. Two-dimensional nuclear Overhauser effect spectra. J. Magn. Reson. 1984;57:404–426. [Google Scholar]
- 68.Borgias BA, James TL. Two-dimensional nuclear Overhauser effect: Complete relaxation matrix analysis. Methods Enzymol. 1989;176:169–183. doi: 10.1016/0076-6879(89)76011-0. [DOI] [PubMed] [Google Scholar]
- 69.Borgias BA, James TL. MARDIGRAS--a procedure for matrix analysis of relaxation for discerning geometry of an aqueous structure. J. Magn. Reson. 1990;87:475–487. [Google Scholar]
- 70.Liu H, Spielmann HP, Ulyanov NB, Wemmer DE, James TL. Interproton distance bounds from 2D NOE intensities: effect of experimental noise and peak integration errors. J. Biomol. NMR. 1995;6:390–402. doi: 10.1007/BF00197638. [DOI] [PubMed] [Google Scholar]
- 71.Wang H, Zuiderweg ERP, Glick GD. Solution structure of a disulfide cross-linked DNA hairpin. J. Am. Chem. Soc. 1995;117:2981–2991. [Google Scholar]
- 72.Geen H, Freeman R. Band-selective radiofrequency pulses. J. Magn. Reson. 1991;93:93–141. [Google Scholar]
- 73.Lankhorst PP, Haasnoot AG, Erkelens C, Altona C. Carbon-13 NMR in conformational analysis of nucleic acid fragments. 3. The magnitude of torsional angle in d(TpA) from CCOP and HCOP NMR coupling constants. Nucleic Acids Res. 1984;12:5419–5428. doi: 10.1093/nar/12.13.5419. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 74.Arnott S, Hukins DWL. Optimised parameters for A-DNA and B-DNA. Biochem. Biophys. Res. Comm. 1972;47:1504–1509. doi: 10.1016/0006-291X(72)90243-4. [DOI] [PubMed] [Google Scholar]
- 75.Case DA, Pearlman DA, Caldwell JW, Cheatham TE, III, Wang J, Ross WS, Simmerling CL, Darden TA, Merz KM, Stanton RV, Cheng AL, Vincent JJ, Crowley M, Tsui V, Gohlke H, Radmer RJ, Duan Y, Pitera J, Massova I, Seibel GL, Singh UC, Weiner PK, Kollman PA. AMBER 7.0. San Francisco, CA: University of California; 2002. [Google Scholar]
- 76.Clore GM, Brunger AT, Karplus M, Gronenborn AM. Application of molecular dynamics with interproton distance restraints to three-dimensional protein structure determination. J. Mol. Biol. 1986;191:523–551. doi: 10.1016/0022-2836(86)90146-4. [DOI] [PubMed] [Google Scholar]
- 77.Ryckaert J-P, Ciccotti G, Berendsen HJC. Numerical integration of the cartesian equations of motion of a system with constraints: Molecular dynamics of n-alkanes. J. Comp. Phys. 1977;23:327–341. [Google Scholar]
- 78.Bashford D, Case DA. Generalized Born models of macromolecular solvation effects. Ann. Rev. Phys. Chem. 2000;51:129–152. doi: 10.1146/annurev.physchem.51.1.129. [DOI] [PubMed] [Google Scholar]
- 79.Tsui V, Case DA. Theory and applications of the generalized Born solvation model in macromolecular simulations. Biopolymers. 2000;56:275–291. doi: 10.1002/1097-0282(2000)56:4<275::AID-BIP10024>3.0.CO;2-E. [DOI] [PubMed] [Google Scholar]
- 80.Cornell WD, Cieplak P, Bayly CI, Gould IR, Merz KM, Ferguson DM, Spellmeyer DC, Fox T, Caldwell JW, Kollman PA. A second generation force field for the simulation of proteins, nucleic acids, and organic molecules. J. Am. Chem. Soc. 1995;117:5179. [Google Scholar]
- 81.Lu XJ, Olson WK. 3DNA: A software package for the analysis, rebuilding and visualization of three-dimensional nucleic acid structures. Nucleic Acids Res. 2003;31:5108–5121. doi: 10.1093/nar/gkg680. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 82.Patel DJ, Shapiro L, Hare D. DNA and RNA: NMR studies of conformations and dynamics in solution. Q. Rev. Biophys. 1987;20:35–112. doi: 10.1017/s0033583500004224. [DOI] [PubMed] [Google Scholar]
- 83.Reid BR. Sequence-specific assignments and their use in NMR studies of DNA structure. Q. Rev. Biophys. 1987;20:2–28. doi: 10.1017/s0033583500004212. [DOI] [PubMed] [Google Scholar]
- 84.Feng B, Stone MP. Solution structure of an oligodeoxynucleotide containing the human N-ras codon 61 sequence refined from 1H NMR using molecular dynamics restrained by nuclear overhauser effects. Chem. Res. Toxicol. 1995;8:821–832. doi: 10.1021/tx00048a002. [DOI] [PubMed] [Google Scholar]
- 85.Nikonowicz EP, Gorenstein DG. Two-dimensional 1H and 31P NMR spectra and restrained molecular dynamics structure of a mismatched GA decamer oligodeoxyribonucleotide duplex. Biochemistry. 1990;29:8845–8858. doi: 10.1021/bi00489a048. [DOI] [PubMed] [Google Scholar]
- 86.Koo HS, Crothers DM. Calibration of DNA curvature and a unified description of sequence-directed bending. Proc. Natl. Acad. Sci. USA. 1988;85:1763–1767. doi: 10.1073/pnas.85.6.1763. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 87.Jelitto B, Vangala RR, Laib RJ. Species differences in DNA damage by butadiene: Role of diepoxybutane. Arch. Toxicol. Suppl. 1989;13:246–249. doi: 10.1007/978-3-642-74117-3_42. [DOI] [PubMed] [Google Scholar]
- 88.Cochrane JE, Skopek TR. Mutagenicity of 1,3-butadiene and its epoxide metabolites in human TK6 cells and in splenic T cells isolated from exposed B6c3F1 mice. IARC Sci. Publ. 1993;127:195–204. [PubMed] [Google Scholar]
- 89.Cochrane JE, Skopek TR. Mutagenicity of butadiene and its epoxide metabolites: II. Mutational spectra of butadiene, 1,2-epoxybutene and diepoxybutane at the hprt locus in splenic T cells from exposed B6c3F1 mice. Carcinogenesis. 1994;15:719–723. doi: 10.1093/carcin/15.4.719. [DOI] [PubMed] [Google Scholar]
- 90.Selzer RR, Elfarra AA. Characterization of N1- and N6-adenosine adducts and N1-inosine adducts formed by the reaction of butadiene monoxide with adenosine: Evidence for the N1-adenosine adducts as major initial products. Chem. Res. Toxicol. 1996;9:875–881. doi: 10.1021/tx960039a. [DOI] [PubMed] [Google Scholar]
- 91.Tretyakova N, Lin Y, Sangaiah R, Upton PB, Swenberg JA. Identification and quantitation of DNA adducts from calf thymus DNA exposed to 3,4-epoxy-1-butene. Carcinogenesis. 1997;18:137–147. doi: 10.1093/carcin/18.1.137. [DOI] [PubMed] [Google Scholar]
- 92.Tretyakova N, Lin YP, Upton PB, Sangaiah R, Swenberg JA. Macromolecular adducts of butadiene. Toxicology. 1996;113:70–76. doi: 10.1016/0300-483x(96)03429-4. [DOI] [PubMed] [Google Scholar]
- 93.Scholdberg TA, Nechev LV, Merritt WK, Harris TM, Harris CM, Lloyd RS, Stone MP. Structure of a site specific major groove (2S,3S)-N6-(2,3,4-trihydroxybutyl)-2'-deoxyadenosyl DNA adduct of butadiene diol epoxide. Chem. Res. Toxicol. 2004;17:717–730. doi: 10.1021/tx034271+. [DOI] [PubMed] [Google Scholar]
- 94.Merritt WK, Scholdberg TA, Nechev LV, Harris TM, Harris CM, Lloyd RS, Stone MP. Stereospecific structural perturbations arising from adenine N6 butadiene triol adducts in duplex DNA. Chem. Res. Toxicol. 2004;17:1007–1019. doi: 10.1021/tx049908j. [DOI] [PubMed] [Google Scholar]
- 95.Feng B, Voehler MW, Zhou L, Passarelli M, Harris CM, Harris TM, Stone MP. Major groove S-α-(N6-adenyl)-styrene oxide adducts in an oligodeoxynucleotide containing the human N-ras codon 61 sequence: Conformations of the S(61,2) and S(61,3) sequence isomers from 1H NMR. Biochemistry. 1996;35:7316–7329. doi: 10.1021/bi952526f. [DOI] [PubMed] [Google Scholar]
- 96.Feng B, Zhou L, Passarelli M, Harris CM, Harris TM, Stone MP. Major groove (R)-α-(N6-adenyl)styrene oxide adducts in an oligodeoxynucleotide containing the human N-ras codon 61 sequence: Conformations of the R(61,2) and R(61,3) sequence isomers from 1H NMR. Biochemistry. 1995;34:14021–14036. doi: 10.1021/bi00043a008. [DOI] [PubMed] [Google Scholar]
- 97.Hennard C, Finneman J, Harris CM, Harris TM, Stone MP. The nonmutagenic (R)- and (S)-β-(N6-adenyl)styrene oxide adducts are oriented in the major groove and show little perturbation to DNA structure. Biochemistry. 2001;40:9780–9791. doi: 10.1021/bi010564v. [DOI] [PubMed] [Google Scholar]
- 98.Painter SL, Zegar IS, Tamura PJ, Bluhm S, Harris CM, Harris TM, Stone MP. Influence of the R(61,2)- and S(61,2)-α-(N6-adenyl)styrene oxide adducts on the A:C mismatched base pair in an oligodeoxynucleotide containing the human N-ras codon 61. Biochemistry. 1999;38:8635–8646. doi: 10.1021/bi9900323. [DOI] [PubMed] [Google Scholar]
- 99.Simeonov MF, Tamura PJ, Wilkinson AS, Harris CM, Harris TM, Stone MP. Sequence- and stereospecific conformational rearrangement of styrene oxide adducts located at A x C mismatched base pairs. Biochemistry. 2000;39:924–937. doi: 10.1021/bi992080t. [DOI] [PubMed] [Google Scholar]
- 100.Recio L, Saranko CJ, Steen AM. 1,3-butadiene: Cancer, mutations, and adducts. Part II: Roles of two metabolites of 1,3-butadiene in mediating its in vivo genotoxicity. Res. Rep. Health Eff. Inst. 2000:49–87. discussion 141–149. [PubMed] [Google Scholar]
- 101.Recio L, Steen AM, Pluta LJ, Meyer KG, Saranko CJ. Mutational spectrum of 1,3-butadiene and metabolites 1,2-epoxybutene and 1,2,3,4-diepoxybutane to assess mutagenic mechanisms. Chem. Biol. Interact. 2001;135–136:325–341. doi: 10.1016/s0009-2797(01)00220-4. [DOI] [PubMed] [Google Scholar]
- 102.Sisk SC, Pluta LJ, Bond JA, Recio L. Molecular analysis of lacI mutants from bone marrow of B6c3F1 transgenic mice following inhalation exposure to 1,3-butadiene. Carcinogenesis. 1994;15:471–477. doi: 10.1093/carcin/15.3.471. [DOI] [PubMed] [Google Scholar]
- 103.Recio L, Meyer KG. Increased frequency of mutations at A:T base pairs in the bone marrow of B6c3F1 lacI transgenic mice exposed to 1,3-butadiene. Environ. Mol. Mutagen. 1995;26:1–8. doi: 10.1002/em.2850260102. [DOI] [PubMed] [Google Scholar]
- 104.Steen AM, Meyer KG, Recio L. Analysis of hprt mutations occurring in human TK6 lymphoblastoid cells following exposure to 1,2,3,4-diepoxybutane. Mutagenesis. 1997;12:61–67. doi: 10.1093/mutage/12.2.61. [DOI] [PubMed] [Google Scholar]
- 105.Goodrow TL, Nichols WW, Storer RD, Anderson MW, Maronpot RR. Activation of H-ras is prevalent in 1,3-butadiene-induced and spontaneously occurring murine Harderian gland tumors. Carcinogenesis. 1994;15:2665–2667. doi: 10.1093/carcin/15.11.2665. [DOI] [PubMed] [Google Scholar]
- 106.Tretyakova N. Yu, Chiang SY, Walker VE, Swenberg JA. Quantitative analysis of 1,3-butadiene-induced DNA adducts in vivo and in vitro using liquid chromatography electrospray ionization tandem mass spectrometry. J. Mass Spectrom. 1998;33:363–376. doi: 10.1002/(SICI)1096-9888(199804)33:4<363::AID-JMS643>3.0.CO;2-E. [DOI] [PubMed] [Google Scholar]
- 107.Tretyakova N. Yu, Lin YP, Upton PB, Sangaiah R, Swenberg JA. Macromolecular adducts of butadiene. Toxicology. 1996;113:70–76. doi: 10.1016/0300-483x(96)03429-4. [DOI] [PubMed] [Google Scholar]
- 108.Tretyakova N. Yu, Sangaiah R, Yen TY, Swenberg JA. Synthesis, characterization, and in vitro quantitation of N-7-guanine adducts of diepoxybutane. Chem. Res. Toxicol. 1997;10:779–785. doi: 10.1021/tx970004q. [DOI] [PubMed] [Google Scholar]
- 109.Selzer RR, Elfarra AA. In vitro reactions of butadiene monoxide with single- and double-stranded DNA: Characterization and quantitation of several purine and pyrimidine adducts. Carcinogenesis. 1999;20:285–292. doi: 10.1093/carcin/20.2.285. [DOI] [PubMed] [Google Scholar]
- 110.Millard JT, Raucher S, Hopkins PB. Mechlorethamine cross-links deoxyguanosine residues at 5'-GNC sequences in duplex DNA fragments. J. Am. Chem. Soc. 1990;112:2459–2460. [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Supplementary Materials
The Supporting Information contains Table S1, showing the 1H chemical shift assignments for the ras61 (R,R) N6,N6-dA crosslink, Table S2, showing the NOE restraints utilized in the rMD calculations for the (R,R) N6,N6-dA crosslink, and Figure S1, showing force field parameters for the (R,R) N6,N6-dA crosslink. This material is available free of charge via the Internet at http://pubs.acs.org.












